Gå till innehåll

Kommersiellt obunden läkemedelsinformation riktad till läkare och sjukvårdspersonal

Cabazitaxel

Summary

Persistence. Cabazitaxel is potentially persistent.

Bioaccumulation. Cabazitaxel has low potential for bioaccumulation.

Toxicity. Cabazitaxel has very high chronic toxicity.

Risk. The use of cabazitaxel (sales data Sweden 2015) has been considered to result in insignificant environmental risk.

 

This summary information comes from fass.se.

Detailed information

Fass environmental information

Fass environmental information for Jevtana (cabazitaxel) (downloaded 2018-06-26).

Hazard

Persistence: Test showed 17.76 % degradation in 28 days (guideline OECD 301B).

Bioaccumulation: Log Pow = 3.78 at pH 7 (guideline OECD 107).

Chronic toxicity: There is NOEC for 3 trophic levels, lowest NOEC 21 days for crustacean (Daphnia magna) 8.9 microg/L.

Risk

PEC/PNEC is based on sales data in Sweden in year 2015. PEC/PNEC = 0.00000843, which gives the risk insignificant.

Author: Health and Medical Care Administration, Region Stockholm